TD Cowen维持默沙东“持有”评级,认为癌症疫苗成功未完全消除不确定性

智通财经
Aug 21
【TD Cowen维持默沙东“持有”评级,认为癌症疫苗成功未完全消除不确定性】TD Cowen维持默沙东“持有”评级,认为癌症疫苗成功未完全消除不确定性尽管制药巨头默沙东本周三宣布其癌症疫苗在大型试验中取得成功,但TD Cowen依然维持对该股的“持有”评级。TD Cowen分析师Steve Scala在周四给客户的一份报告中指出:“鉴于此前强劲的二期临床数据,此次成功并不令人感到意外。积极的结果确实起到了验证作用,但其潜在应用的广度目前仍属未知。”目前,TD Cowen为默沙东设定的目标价为137美元,而该股在周三的收盘价为152.20美元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10